TORONTO & SAN FRANCISCO, February 14, 2024 Treadwell Therapeutics, a privately held clinical-stage biotechnology company pioneering and advancing novel first-in-class medicines for unmet needs in cancer, today announced the formation of a Scientific Advisory Board comprised of prominent oncology leaders and drug developers. The SAB will work closely with Treadwell to advance the company’s pipeline of small molecules, biologics and cell therapies.
PDC*line Pharma and Partners Receive €8 1M From Walloon Region and Wallonia Health Cluster BioWin for Personalized Therapeutic Vaccine Project finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
AGOURA HILLS, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), announced.